Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report)’s share price traded down 13.2% on Tuesday. The stock traded as low as $0.62 and last traded at $0.6250. 5,350 shares changed hands during trading, an increase of 93% from the average session volume of 2,773 shares. The stock had previously closed at $0.72.
Ascletis Pharma Stock Performance
The business’s 50-day moving average price is $0.96 and its 200-day moving average price is $1.51.
Ascletis Pharma Company Profile
Ascletis Pharma Inc. is a China-based biopharmaceutical company focused on discovering, developing and commercializing innovative medicines. The company’s research and development activities have centered on viral diseases, liver diseases, oncology and metabolic disorders, with an emphasis on therapies addressing significant unmet medical needs. Ascletis has developed and commercialized treatments for hepatitis C, including danoprevir, marketed in China under the brand name Ganovo. The company has also advanced additional antiviral programs and drug candidates targeting infectious diseases, while expanding its pipeline into areas such as cancer and metabolic disease.
Further Reading
- Five stocks we like better than Ascletis Pharma
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
